These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 1649745)
1. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745 [TBL] [Abstract][Full Text] [Related]
2. The 1,25-dihydroxy-vitamin D3 receptor is phosphorylated in response to 1,25-dihydroxy-vitamin D3 and 22-oxacalcitriol in rat osteoblasts, and by casein kinase II, in vitro. Jurutka PW; Terpening CM; Haussler MR Biochemistry; 1993 Aug; 32(32):8184-92. PubMed ID: 8394128 [TBL] [Abstract][Full Text] [Related]
3. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways. Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551 [TBL] [Abstract][Full Text] [Related]
4. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). Liel Y; Kraus S; Levy J; Shany S Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250 [TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo. Reinhardt TA; Horst RL Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926 [TBL] [Abstract][Full Text] [Related]
6. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone. van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716 [TBL] [Abstract][Full Text] [Related]
7. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8. Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627 [TBL] [Abstract][Full Text] [Related]
8. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012 [TBL] [Abstract][Full Text] [Related]
9. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Skowronski RJ; Peehl DM; Feldman D Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193 [TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs. Musiol IM; Feldman D Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379 [TBL] [Abstract][Full Text] [Related]
11. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Chen TL; Hauschka PV; Cabrales S; Feldman D Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737 [TBL] [Abstract][Full Text] [Related]
12. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965 [TBL] [Abstract][Full Text] [Related]
13. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells. Chen TL; Hauschka PV; Feldman D Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896 [TBL] [Abstract][Full Text] [Related]
14. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol. Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029 [TBL] [Abstract][Full Text] [Related]
15. Structure-function relationship of human parathyroid hormone in the regulation of vitamin D receptor expression in osteoblast-like cells (ROS 17/2.8). Sriussadaporn S; Wong MS; Whitfield JF; Tembe V; Favus MJ Endocrinology; 1995 Sep; 136(9):3735-42. PubMed ID: 7649079 [TBL] [Abstract][Full Text] [Related]
16. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3. Van Auken M; Buckley D; Ray R; Holick MF; Baran DT J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881 [TBL] [Abstract][Full Text] [Related]
17. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells. Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708 [TBL] [Abstract][Full Text] [Related]
18. 17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells. Ishibe M; Nojima T; Ishibashi T; Koda T; Kaneda K; Rosier RN; Puzas JE Calcif Tissue Int; 1995 Dec; 57(6):430-5. PubMed ID: 8581875 [TBL] [Abstract][Full Text] [Related]
19. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3. Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186 [TBL] [Abstract][Full Text] [Related]
20. Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone. van Leeuwen JP; Birkenhäger JC; van den Bemd GJ; Buurman CJ; Staal A; Bos MP; Pols HA J Biol Chem; 1992 Jun; 267(18):12562-9. PubMed ID: 1320001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]